> Pfizer, which previously received a warning letter for the Meridian Medical Technologies plant that makes EpiPen injectors for Mylan, has reported to Health Canada that manufacturing problems have led to a shortage of the 0.3 mg format of the pen which it expects to have resolved by March 2, 2018. Release
> The FDA says that the shortage of saline has now led to a shortage of empty IV bags which healthcare providers have been using for compounded versions of the solution. Release
> Wuhan Chinese Moxibustion Technology Dev. Co., a maker of an updated version of a traditional Chinese medicine, has received an FDA warning letter for GMP failures at its plant in Wuhan, Hubei, China. Letter